Difficulty: Medium
Average Score: 63%
Practice
Indication of vitamin D3 is:
Correct answer
D
Rationale
In the context of pharmacological lifespan treatment, the indication of vitamin D3 is primarily for the treatment of conditions related to bone health. The correct answer, option D) Osteomalacia, aligns with this rationale. Osteomalacia is a condition characterized by softening of the bones due to a deficiency in vitamin D, leading to inadequate mineralization of bone matrix. Vitamin D3 plays a crucial role in maintaining proper bone health by aiding in the absorption of calcium and phosphorus, essential minerals for bone strength.
Option A) Hypercalcemia is an incorrect choice because vitamin D3 supplementation can actually exacerbate hypercalcemia, as it increases calcium absorption from the intestines. Hypercalcemia is a condition of elevated levels of calcium in the blood and is not an indication for vitamin D3 therapy.
Option B) Paget's disease is also an incorrect choice as the primary treatment for Paget's disease involves bisphosphonates and not vitamin D3. Paget's disease is characterized by abnormal bone remodeling, leading to enlarged and weakened bones.
Option C) Hypophosphatemia is not a direct indication for vitamin D3 therapy. While vitamin D plays a role in regulating phosphate levels in the body, the primary treatment for hypophosphatemia involves phosphate supplementation rather than vitamin D3.
In an educational context, it is important for healthcare professionals to understand the specific indications for vitamin D3 supplementation to ensure appropriate treatment of conditions related to bone health. Understanding the role of vitamin D in calcium absorption and bone mineralization is essential in providing effective pharmacological treatment for osteomalacia and other bone-related disorders.
Option A) Hypercalcemia is an incorrect choice because vitamin D3 supplementation can actually exacerbate hypercalcemia, as it increases calcium absorption from the intestines. Hypercalcemia is a condition of elevated levels of calcium in the blood and is not an indication for vitamin D3 therapy.
Option B) Paget's disease is also an incorrect choice as the primary treatment for Paget's disease involves bisphosphonates and not vitamin D3. Paget's disease is characterized by abnormal bone remodeling, leading to enlarged and weakened bones.
Option C) Hypophosphatemia is not a direct indication for vitamin D3 therapy. While vitamin D plays a role in regulating phosphate levels in the body, the primary treatment for hypophosphatemia involves phosphate supplementation rather than vitamin D3.
In an educational context, it is important for healthcare professionals to understand the specific indications for vitamin D3 supplementation to ensure appropriate treatment of conditions related to bone health. Understanding the role of vitamin D in calcium absorption and bone mineralization is essential in providing effective pharmacological treatment for osteomalacia and other bone-related disorders.